|Drug Patent Number||Company||Drug Patent Title||Drug Patent Expiry||Activity Alert|
|These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.|
|US9301948||INTELGENX CORP||Instantly wettable oral film dosage form without surfactant or polyalcohol|| |
(10 years from now)
Rizafilm is owned by Intelgenx Corp.
Rizafilm contains Rizatriptan Benzoate.
Rizafilm has a total of 1 drug patent out of which 0 drug patents have expired.
Rizafilm was authorised for market use on 14 April, 2023.
Rizafilm is available in film;oral dosage forms.
The generics of Rizafilm are possible to be released after 30 July, 2034.
Market Authorisation Date: 14 April, 2023
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic